FTV - Fortive Corporation
NYSE
->
Technology
->
Scientific & Technical Instruments
Everett,
United States
Type: Equity
FTV price evolution
FTV
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1888.8 | $714.1 | $712.8 | $672.8 |
| Short term investments | ||||
| Net receivables | $960.8 | $925.4 | $935.2 | $940.7 |
| Inventory | $536.9 | $552.5 | $561.2 | $570.2 |
| Total current assets | $3671.6 | $2469.3 | $2474.6 | $2455.3 |
| Long term investments | ||||
| Property, plant & equipment | $439.8 | $430.8 | $425.9 | $425.6 |
| Goodwill & intangible assets | $12281.5 | $12285 | $12355.9 | $12453.9 |
| Total noncurrent assets | $13240.2 | $13195.1 | $13256.1 | $13349.5 |
| Total investments | ||||
| Total assets | $16911.8 | $15664.4 | $15730.7 | $15804.8 |
| Current liabilities | ||||
| Accounts payable | $608.6 | $574.8 | $585.6 | $593 |
| Deferred revenue | ||||
| Short long term debt | $749.9 | $999.9 | $999.8 | |
| Total current liabilities | $2340.6 | $2420 | $2585 | $2630.1 |
| Long term debt | $3096.9 | $1982.1 | $1978.2 | $2094.6 |
| Total noncurrent liabilities | $4795.2 | $3160.8 | $3173.9 | $3299 |
| Total debt | $3646.2 | $2732 | $2978.1 | $3094.4 |
| Total liabilities | $6592.9 | $5580.8 | $5758.9 | $5929.1 |
| Shareholders' equity | ||||
| Retained earnings | $7505.9 | $7268.8 | $7075.4 | $6891 |
| Other shareholder equity | -$326.1 | -$365.8 | -$319.9 | -$312.3 |
| Total shareholder equity | $10318.9 | $10077.8 | $9965.8 | $9869.9 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1888.8 | $709.2 | $819.3 | $1824.8 |
| Short term investments | $1119.2 | |||
| Net receivables | $960.8 | $958.5 | $930.2 | $810.3 |
| Inventory | $536.9 | $536.7 | $512.7 | $455.5 |
| Total current assets | $3671.6 | $2477 | $2514.9 | $4446.9 |
| Long term investments | ||||
| Property, plant & equipment | $439.8 | $421.9 | $571.1 | $610.7 |
| Goodwill & intangible assets | $12281.5 | $12535.9 | $13042.2 | $10649.8 |
| Total noncurrent assets | $13240.2 | $13413.6 | $13950.6 | $11604.6 |
| Total investments | $1119.2 | |||
| Total assets | $16911.8 | $15890.6 | $16465.5 | $16051.5 |
| Current liabilities | ||||
| Accounts payable | $608.6 | $623 | $557.9 | $480.8 |
| Deferred revenue | ||||
| Short long term debt | $999.7 | $2196.3 | $1446.8 | |
| Total current liabilities | $2340.6 | $2727.1 | $3714.9 | $2860.8 |
| Long term debt | $3096.9 | $2251.6 | $1947.2 | $2984.6 |
| Total noncurrent liabilities | $4795.2 | $3474.9 | $3233.6 | $4218 |
| Total debt | $3646.2 | $3251.3 | $4143.5 | $4431.4 |
| Total liabilities | $6592.9 | $6207.2 | $6948.5 | $7078.8 |
| Shareholders' equity | ||||
| Retained earnings | $7505.9 | $6742.1 | $6023.6 | $5547.4 |
| Other shareholder equity | -$326.1 | -$325.7 | -$185 | -$141.1 |
| Total shareholder equity | $10318.9 | $9683.4 | $9512.2 | $8964.2 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1583.7 | $1494.5 | $1526.4 | $1460.7 |
| Cost of revenue | $601.5 | $621 | $612.5 | |
| Gross Profit | $947.5 | $893 | $905.4 | $848.2 |
| Operating activities | ||||
| Research & development | $98.4 | $100.1 | $100.1 | |
| Selling, general & administrative | $503.5 | $514 | $507.7 | |
| Total operating expenses | $636.6 | $601.9 | $614.1 | $607.8 |
| Operating income | $291.1 | $291.3 | $240.4 | |
| Income from continuing operations | ||||
| EBIT | $286.9 | $283.5 | $237.9 | |
| Income tax expense | $12.3 | $39.1 | $41.4 | $32.2 |
| Interest expense | -$28.5 | $29.8 | $33.1 | $32.1 |
| Net income | ||||
| Net income | $265.2 | $218 | $209 | $173.6 |
| Income (for common shares) | $218 | $209 | $173.6 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6065.3 | $5825.7 | $4634.4 | |
| Cost of revenue | $2462.3 | $2025.9 | ||
| Gross Profit | $3594.1 | $3363.4 | $2608.5 | |
| Operating activities | ||||
| Research & development | $401.5 | $320.7 | ||
| Selling, general & administrative | $1956.6 | $1748.4 | ||
| Total operating expenses | $2460.4 | $2376 | $2069.1 | |
| Operating income | $987.4 | $539.4 | ||
| Income from continuing operations | ||||
| EBIT | $971.8 | $1817.3 | ||
| Income tax expense | $125 | $118.3 | $55.5 | |
| Interest expense | -$123.5 | $98.3 | $148.5 | |
| Net income | ||||
| Net income | $865.8 | $755.2 | $1613.3 | |
| Income (for common shares) | $755.2 | $1544.3 | ||
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $218 | $209 | $173.6 | |
| Operating activities | ||||
| Depreciation | $114.8 | $113.5 | $112.8 | |
| Business acquisitions & disposals | -$57.7 | |||
| Stock-based compensation | $29.5 | $29 | $26.7 | |
| Total cash flows from operations | $411.4 | $321 | $174.4 | |
| Investing activities | ||||
| Capital expenditures | -$25.6 | -$16.1 | -$24.8 | |
| Investments | ||||
| Total cash flows from investing | -$195.4 | -$83.3 | -$16.1 | -$24.8 |
| Financing activities | ||||
| Dividends paid | -$102 | -$24.6 | -$24.6 | -$24.7 |
| Sale and purchase of stock | -$78.8 | -$129.1 | ||
| Net borrowings | -$234 | -$109.3 | -$159.3 | |
| Total cash flows from financing | $32.3 | -$324.9 | -$254.3 | -$187.1 |
| Effect of exchange rate | -$10.9 | -$1.9 | -$10.6 | $1.1 |
| Change in cash and equivalents | $1179.6 | $1.3 | $40 | -$36.4 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $755.2 | $608.4 | $1613.3 | |
| Operating activities | ||||
| Depreciation | $465.6 | $395.5 | $384 | |
| Business acquisitions & disposals | -$12.8 | -$2570.1 | -$40.4 | |
| Stock-based compensation | $93.8 | $77.4 | $62.6 | |
| Total cash flows from operations | $1303.2 | $961.1 | $1436.7 | |
| Investing activities | ||||
| Capital expenditures | -$86.2 | -$45.5 | -$70.4 | |
| Investments | ||||
| Total cash flows from investing | -$195.4 | -$102.5 | -$2615.6 | -$148.4 |
| Financing activities | ||||
| Dividends paid | -$102 | -$99.5 | -$97.7 | -$94.4 |
| Sale and purchase of stock | -$442.9 | |||
| Net borrowings | -$723.9 | $753.6 | -$2131 | |
| Total cash flows from financing | $32.3 | -$1273 | $652 | -$696.1 |
| Effect of exchange rate | -$10.9 | -$37.8 | -$3 | $27.4 |
| Change in cash and equivalents | $1179.6 | -$110.1 | -$1005.5 | $619.6 |
News
Fundamentals
| Market cap | $27.88B |
|---|---|
| Enterprise value | $29.63B |
| Shares outstanding | 350.70M |
| Revenue | $6.07B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $865.80M |
| Revenue Q/Q | 3.52% |
| Revenue Y/Y | 4.11% |
| P/E ratio | 32.20 |
|---|---|
| EV/Sales | 4.89 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 4.60 |
| P/B ratio | 2.62 |
| Book/Share | 30.35 |
| Cash/Share | 5.39 |
| EPS | $2.47 |
|---|---|
| ROA | 5.40% |
| ROE | 8.61% |
| Debt/Equity | 0.64 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.57 |
| Quick ratio | 1.34 |